Editas Medicine (EDIT) EBITDA (2015 - 2025)
Editas Medicine's (EDIT) quarterly EBITDA came in at -$24.5 million in Q3 2025, up 62.62% year-on-year from -$15.1 million in Q3 2024, and up 52.37% on a QoQ basis from -$51.5 million in Q2 2025.
Editas Medicine (EDIT) EBITDA (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of EBITDA data on file, last reported at -$24.5 million in Q3 2025.
- On a quarterly basis, EBITDA rose 62.62% year-over-year to -$24.5 million in Q3 2025; TTM through Sep 2025 was -$198.8 million, a 12.99% increase from a year earlier, with the FY2024 full-year figure at -$251.2 million, down 48.45% from the prior year.
- EBITDA for Q3 2025 stood at -$24.5 million, up from -$51.5 million in the prior quarter.
- Over the last five years, EBITDA for EDIT reached as high as -$24.0 million in Q4 2023 and fell as low as -$76.2 million in Q1 2025.
- Historically, EBITDA has averaged -$52.2 million across 5 years, with a median of -$51.5 million in 2025.
- Across the five-year window, EBITDA plunged 536.68% in 2021 and jumped 62.62% in 2025, its largest moves.
- Year by year, EBITDA stood at -$41.6 million in 2021, then tumbled by 52.48% to -$63.4 million in 2022, then jumped by 62.23% to -$24.0 million in 2023, then sank by 94.45% to -$46.6 million in 2024, then jumped by 47.31% to -$24.5 million in 2025.
- Per Business Quant data, the three most recent EBITDA figures were -$24.5 million in Q3 2025, -$51.5 million in Q2 2025, and -$76.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -24.55 Mn |
| Jun 30, 2025 | -51.54 Mn |
| Mar 31, 2025 | -76.16 Mn |
| Dec 31, 2024 | -46.59 Mn |
| Sep 30, 2024 | -65.67 Mn |
| Jun 30, 2024 | -71.90 Mn |
| Mar 31, 2024 | -66.99 Mn |
| Dec 31, 2023 | -23.96 Mn |
| Sep 30, 2023 | -50.16 Mn |
| Jun 30, 2023 | -44.09 Mn |
| Mar 31, 2023 | -50.96 Mn |
| Dec 31, 2022 | -63.45 Mn |
| Sep 30, 2022 | -57.52 Mn |
| Jun 30, 2022 | -54.23 Mn |
| Mar 31, 2022 | -50.75 Mn |
| Dec 31, 2021 | -41.61 Mn |
| Sep 30, 2021 | -39.25 Mn |
| Jun 30, 2021 | -55.40 Mn |
| Mar 31, 2021 | -56.88 Mn |
| Dec 31, 2020 | -65.87 Mn |